Building the world’s first portable, clinic-ready therapeutic ultrasound for Alzheimer’s diseaseInvestor Presentation - October 2026ASX: CTSDisclaimerThis presentation has been prepared by Ceretas Limited and its related entities (the “Company”) and is not an offer document. It does not...
Investor Presentation - October 2026
Filed with ASX · · 19 pages · English
Release
In the deck
Story so far
Earlier from Ceretas
- Date of AGM and Closing Date for Director Nominations
- Milestone 3 Completed for CUREator Program
- Ethics Committee Approval Secured for Additional Trial Sites
- Appendix 4G
- Corporate Governance Statement
Later from Ceretas
- Notice of Annual General Meeting/Proxy Form
- First Patient Enrolled in Phase 2 CERE-CALM Clinical Trial
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Ceretas into a list and get an email when it puts out news.
Follow Ceretas